Skip to main content

Table 4 sCD36 and oxLDL levels according to metabolic abnormalities

From: Circulating CD36 and oxLDL levels are associated with cardiovascular risk factors in young subjects

Variables (n)

sCD36 levels (ng/mL)

oxLDL levels (U/L)

Fasting glucose (>100 mg/dL)

  

No (176)

47.7 (18.4-219.9)

37.8 (29.5-50.6)

Yes (12)

62.2 (16.7-200.4)

52.7 (30.1-60.5)

P = 0.93

P = 0.20

Hypercholesterolemia (≥200 mg/dL)

  

No (162)

44.9 (17.3-223.6)

36.7 (29.1-48.5)

Yes (26)

74.8 (25.7-98.7)

54.5 (45.5-65.0)

P = 0.55

P = 0.0002

Fasting LDL-C (>100 mg/dL)

  

No (95)

47.7 (17.2-208.2)

32.4 (27.8-45.6)

Yes (93)

74.8 (21.8-270.4)

47.1 (35.8-57.1)

P = 0.30

P = 0.0001

Fasting HDL-C (<40 mg/dL)

  

No (88)

61.1 (19.6-262)

45.6 (31.9-54.3)

Yes (100)

46.7 (17.9-127.2)

34.6 (29-48.5)

P = 0.49

P = 0.06

Hypertriglyceridemia (≥150 mg/dL)

  

No (161)

43.1 (16.7-190.6)

36.1 (28.2-48.1)

Yes (27)

180.3 (66.01-2295)

52.5 (48.5-59.7)

P = 0.01

P = 0.0001

Hypertension (SBP ≥140 mmHg, DBP ≥ 90 mmHg)

  

No (161)

34.1 (16.7-190.6)

37.6 (29–119.0)

Yes (27)

79.8 (66.01-200.4)

48.0 (31.5-58.8)

 

P = 0.03

P = 0.1218

  1. The values were presented as median (percentile 25-75th). The difference between genders was determined by the Wilcoxon-Mann–Whitney test.